All memory T cells mount an accelerated response on antigen reencounter, but significant functional heterogeneity is present within the respective memory T-cell subsets as defined by CCR7 and CD45RA expression, thereby warranting further stratification. Here we show that several surface markers, including KLRB1, KLRG1, GPR56, and KLRF1, help define low, high, or exhausted cytokine producers within human peripheral and intrahepatic CD4 + memory T-cell populations. Highest simultaneous production of TNF and IFN-γ is observed in KLRB1 + KLRG1 + GPR56 + CD4 T cells. By contrast, KLRF1 expression is associated with T-cell exhaustion and reduced TNF/IFN-γ production. Lastly, TCRβ repertoire analysis and in vitro differentiation support a regulated, progressive expression for these markers during CD4 + memory T-cell differentiation. Our results thus help refine the classification of human memory T cells to provide insights on inflammatory disease progression and immunotherapy development.
C D4 + helper T cells coordinate the immune response against invading pathogens and malignancies [1] [2] [3] [4] [5] . However, they also play a pathological role in the development of various inflammatory and/or autoimmune disorders 6, 7 .
In association to their differentiation state, CD4 + T-cell populations vary in their migratory behavior, cytokine production, and proliferative capacity, as well as effector function 8, 9 . Naive T cells (T N ) upon primary antigen encounter in secondary lymphoid organs exert only delayed effector functions 10, 11 . In contrast, memory T cells show an accelerated and intensified response to antigen re-encounter resulting in rapid antigen clearance. However, the functional repertoire of memory T cells is manifold and subpopulations vary in their location, protection capacity, and longevity 10, 11 . Therefore, researchers have urged to identify phenotypic properties that help to distinguish memory T-cell subpopulations 12, 13 . Based on the expression patterns of lymph node homing receptors (CD62L or CCR7) and CD45 splice variants, CD8 + and CD4 + T cells have been classified into CD45RA + CCR7 + naive (T N ), CD45RA − CCR7 + central memory (T CM ), CD45RA − CCR7 − effector memory (T EM ), and CD45RA + CCR7 − terminally differentiated effector memory (T EMRA ) cells [14] [15] [16] . T CM being CCR7 + , such as T N cells, circulate between blood and lymphoid compartments, and have a high proliferative and self-renewal capacity. Both CCR7 − T EM and T EMRA subsets are excluded from lymphatic organs and migrate via the blood to peripheral tissue 15, 16 where they elicit an immediate cytokine-driven cytotoxic immune response against re-occurring infections 9, 17 . Although T EM cells show generally high cytokine production potential, contrasting findings have been published for T EMRA cells, reporting either high or low cytokine production potential; the latter being attributed to an exhausted state with characteristics of end-stage differentiation, showing acquirement of killer cell lectin-like G1 (KLRG1) and CD57 but loss of CD28 and CD27 expression 9, [18] [19] [20] [21] . Similar findings suggesting multifunctionality within a subset have also been observed for T EM cells 21, 22 . Thus, T EM and T EMRA populations defined by the CD45RA/CCR7 classification seem to represent a pool of cells, which are functionally and phenotypically heterogeneous. This is particularly true for CD4 + memory T cells.
Due to their high pro-inflammatory cytokine production potential, CD4 + memory T cells are key promoters of chronic inflammation when physiological regulatory circuits fail. Therefore, it is not surprising that increased proportions and absolute numbers of T EM and also T EMRA cells have been observed in patients suffering from chronic inflammatory diseases 23, 24 . However, due to high intra-subset heterogeneity and possible partial functional overlap of T EM and T EMRA , it seems likely to be that T cells with high cytokine secretion properties might be driving chronic inflammation irrespective of their CD45RA/ CCR7 phenotype.
Therefore, in this study we aim for further characterization of functional heterogeneity of human CD4 + T-cell subsets at the single-cell level, including the identification of reliable surface markers correlating with their cytokine production properties. Here we perform bulk and single cell gene expression profiling of purified human CD4 + T N , T CM , T EM , and T EMRA cells from the peripheral blood of healthy individuals and identify different combinations of the surface markers KLRB1, KLRG1, GPR56, and KLRF1 to be suitable to describe the development of human CD4 + memory T cells with varying cytokine production potential. Expression of KLRB1, KLRG1, and GPR56 is associated with high tumor necrosis factor (TNF)/interferon (IFN)-γ coexpression potential, whereas acquisition of KLRF1 expression during terminal differentiation results in a reduction of the cytokine production capacity. This KLR and GPR56-based classification allows for a more precise definition of functional states of TNF/IFN-γ producers as compared to the classical T EM or T EMRA gating, respectively. Importantly, this correlation between marker expression and cytokine production is also validated in blood and intra-tissue CD4 + T cells from patients with inflammatory liver diseases. Our data thus support a human CD4 + memory T-cell classification scheme that is more precise than the CD45RA/CCR7-based categorization.
Results
Overlapping gene signatures of CD4 + T EM and T EMRA cells. To gain more insights into common vs. different phenotypic and functional properties of CD4 + T EM and particularly T EMRA cells, we performed comparative gene expression profiling of sorted CD4 + T N , T CM , T EM , and T EMRA cells from the peripheral blood of healthy individuals. We focussed on genes encoding cell surface proteins, in order to identify phenotypic markers associated with distinct functional properties (e.g., cytokine production potential) of T EM and especially T EMRA cells. Therefore, we performed an intersection analysis as explained in Methods between T EMRA /T EM vs. T N , or T EMRA /T EM vs. T CM cells (Fig. 1a) , and T EMRA vs. T N , T EMRA vs. T CM , or T EMRA vs. T EM (Fig. 1b) , to identify genes that were highest expressed in T EMRA cells (Fig. 1b) but also significantly increased in both CD4 + T EM and T EMRA cells (Fig. 1a ) compared with CD4 + T N /T CM or with T N cells only (see also Supplementary Table 1) . Among the top-ranked genes upregulated in both CD4 + T EM and T EMRA cells were genes previously shown to be highly expressed in more differentiated T cells (e.g., FASLG) as well as genes encoding various Toll-like receptors or HLA-DR beta chains, but especially genes associated with natural killer (NK) cells. Among those NK cell genes were members of the killer-like receptor family (e.g., KLRG1 and KLRF1, NKG7, CD300A, and CD300C). In addition, genes encoding proteins regulating cell migration and adhesion such as S1PR5, CX3CR1, and ADGRG1 (also known as GPR56) were highly upregulated. Furthermore, the microarray analysis identified genes whose expression was specifically increased in T EM cells, such as genes encoding c-Kit or the killer-like receptor KLRB1 (see also Supplementary Table 1) . Taken together, we could identify a set of genes encoding surface markers, which were significantly higher expressed in more differentiated human CD4 + T EM and T EMRA cells.
Heterogeneity in gene expression of T EMRA and T EM cells. We used the identified CD4 + T EM − and T EMRA -specific genes to investigate whether their expression was homogeneous or could be attributed to certain cell subsets within CD4 + T EM and T EMRA cells. For this, we applied single-cell separation combined with gene candidate-specific quantitative reverse-transcriptase PCR (qRT-PCR) in separated CD4 + T N , T CM , T EM , and T EMRA cells, as well as CD4 + CD25 high CD127 low regulatory T cells (Treg) from healthy individuals. In addition to the expression of our identified gene candidates, we also analyzed expression of TBX21, GATA3, EOMES, RORC, FOXP3, SELL, and CD45RA (see Supplementary  Table 2 for complete gene list). We performed an unsupervised hierarchical cluster analysis of all genes giving a signal in at least ten cells and showing no cross-reactivity with genomic DNA.
Nearly all of the T EMRA and the majority of the T EM cells clustered separately from the other T-cell subsets, which was in part due to the inclusion of lineage-specific genes such as EOMES (Fig. 1c) . Also, as expected, Treg cells clustered separately in a highly homogeneous cluster, underlining the clear separation of this immunosuppressive subset from all other pro-inflammatory subsets. A high proportion of T EM but also T EMRA cells transcribed EOMES and also GATA3, whereas RORC was only expressed by a minor fraction of T CM , T EM , and Treg cells but not by T EMRA cells (Supplementary Table 3) .
Single-cell quantitative PCR (qPCR) analysis not only validated the selective expression pattern of most of the gene candidates observed in bulk analysis but also revealed that only a few CD4 + T EM -and T EMRA -specific genes such as NKG7, GPR56, or KLRG1 were expressed by nearly all T EM and T EMRA cells (Fig. 1c, d and Supplementary Table 3 ). The majority of genes showed a more heterogeneous expression pattern with only a fraction (e.g., KLRB1, KLRF1, CMKLR1, and ADRB2) or sometimes even a minority of CD4 + T EM or T EMRA cells transcribing the genes (e.g., S1PR5, CADM1). The variability in NK cell-associated marker expression (Fig. 1d) was especially apparent.
As we were particularly interested in understanding heterogeneity associated with variations in functionality and differentiation status of the T cells, we investigated the heterogeneously (= GPR56)  CX3CR1  NKG7  S1PR5  CMKLR1  SLAMF1  FASLG  KLRF1  OR10H2  ENPP5  PCDHGA7  CD300A  HRH3  SLC4A4  FZD2  HLA-DRB4  PTCH1  CD300C  KLRG1  LAG3  HLA-DRB1  SLC27A3  MCTP2  HLA-DRB5  FCRL3  HCST  SPN  TLR3  SIGLEC9  SLC8A1  CD99  LILRA6  FCGR2A  LPCAT1  ITGAX  ERBB2  TLR4  SLC2A6   CD300A   ADGRG1 (GPR56)   CMKLR1   ADGRG5 (GPR114)   KLRG1   KLRF1   KLRB1   NKG7   Expressing cell  Non-expressing cell   NKG7  LGR6  ADGRG1 (= GPR56)  ADRB2  FASLG  S1PR5   F2R   SLAMF7  CMKLR1  PTDGDR  ITGAM  SLC2A8  ITPRIPL2  PLXND1  SLAMF8  CCR5  SLC4A4  ENPP5  OR10H2  KLRF1  TGFBR3  ADGRG5 (= GPR114)  SLC04C1  TNFSF14  CRIM1  KLRG1  PCDHGA7  TMCC3  HLA-DRB1  AGPAT4  HRH3  ZDHHC14  SLC27A3  ELOVL6   CD45RA   SELL   FOXP3   RORC   GATA3   EOMES   NKG7   CX3CR1   KLRG1   CD300A   NMUR1   S1PR5   APOBEC3H   CADM1   KLRF1   LAIR2   PTGDR   CMKLR1   ADRB2   ADGRG5 (GPR114)   KLRB1 T reg  T EM   T EMRA   T CM  T EM  T N  T CM  T EM  T EMRA  T expressed genes in more detail at protein level. We concentrated on KLRB1, KLRG1, GPR56, and KLRF1 as we wanted to include markers with homogeneous and those with heterogeneous expression as well. We achieved reproducible high-resolution antibody staining in flow cytometry. We detected a progressive increase in expression of all four markers starting from T N to T EMRA cells (Fig. 2a) with upregulation of KLRB1 at an early memory stage (central memory stage). In contrast, expression of the other three markers increased later during memory/effector cell development: KLRG1 was expressed by~50% of the T EM and nearly all T EMRA cells, whereas GPR56 and especially KLRF1 were particularly upregulated in even later stages of differentiation with only T EMRA cells displaying a relatively high expression of these markers (Fig. 2a) .
Thus, we could validate the selective expression pattern of killer-like receptors and GPR56 in T EM and T EMRA cells. In concordance with the single-cell mRNA expression analysis, the expression patterns were still heterogeneous and not all of the T EM and T EMRA cells stained positive for these four markers.
In addition, we studied expression of co-inhibitory receptors known to become upregulated during T-cell differentiation or Tcell dysfunction/exhaustion such as PD-1 and TIGIT. Of interest, expression of both receptors was highest in T EM or T CM cells, respectively, but reduced in T EMRA cells (Fig. 2a) . Our analysis of other co-inhibitory receptors such as TIM-3 and LAG-3 revealed rather high surface expression on T N and T CM , and low expression on T EM and T EMRA cells ( Supplementary Fig. 1A ), whereas, in contrast, mRNA expression of LAG-3 was only upregulated in T EMRA cells and, to a lesser degree, T EM cells (Fig. 1b) . Supplementary Table 4 summarizes the expression pattern of previously defined and our proposed surface markers on human and murine CD4 + and CD8 + T cells that distinguish between activated, memory, and dysfunctional/exhausted states.
When comparing single-cell expression data on mRNA to respective data on protein level, we observed nearly identical frequencies of GPR56-and KLRG1-expressing cells (Fig. 2b) . In contrast, proportion of KLRF1 and especially KLRB1-positive cells varied significantly for T EMRA cells pointing to fluctuations in gene transcription.
KLR and GPR56 expression-associated cytokine production. Next, we tested a potential correlation between cytokine production of CD4 + T cells and surface marker expression of KLRB1, KLRG1, GPR56, and KLRF1 each. For this, peripheral blood mononuclear cells (PBMCs) of healthy individuals were short-term stimulated using phorbol 12-myristate 13-acetate (PMA)/Ionomycin, followed by staining of the respective surface markers and intracellular cytokines, namely TNF, IFN-γ, interleukin (IL)-4, and IL-17. We observed a general trend of KLRB1 + , KLRG1 + , and GPR56 + T cells displaying high potential to produce cytokines, with especially the KLRG1 + group of cells containing a particular high frequency of TNF and IFN-γ producers (Fig. 3a) . In contrast, IL-4 production showed no association with expression of KLRs and IL-17A production was mostly observed within KLRB1 + cells (Supplementary Fig. 2A ) as previously described 25 . With single KLRB1-expressing CD4 + T cells mainly residing within T CM cells, we detected only IL-17A expression in T CM but not in T EM or T EMRA cells (Supplementary Fig. 2B ). However, total proportion of IL-4 or IL-17A producers was rather low within peripheral CD4 + T cells of healthy controls.
In order to visualize defined co-expression patterns of the surface markers associated with TNF and IFN-γ production, we created t-distributed stochastic neighbor embedding (t-SNE) maps arranging all conventional CD4 + T cells (pre-gated on CD3 + CD4 + cells with exclusion of CD25 high CD127 low Treg cells) according to their similarity in surface marker (CCR7, CD45RA, KLRB1, KLRG1, GPR56, and KLRF1) and cytokine expression (TNF, IFN-γ, IL-4, and IL-17A; Fig. 3b ). The twodimensional shape of all t-SNE plots is based on the overall similarities between the acquired conventional CD4 + T cells. The color code of each t-SNE plot reflects the corresponding distribution of marker-positive and -negative T cells, which, e.g., allows the identification of CCR7-negative, CD45RA-negative, or -positive T EM and T EMRA cells respectively, in the upper left t-SNE plots (encircled black area). TNF and IFN-γ production is common but clearly heterogeneous within the T EM / T EMRA area, with certain subtypes being completely devoid of cytokine expression (blue arrows). In accordance with the singlecell gene expression results, we detected a homogeneous KLRG1 expression in nearly all cells within the T EM /T EMRA area, whereas expression of the other marker was very heterogeneous.
Surprisingly, most cells in this cytokine-low area (blue arrows) express all four surface markers with KLRF1 displaying an almost exclusive expression for the T EM /T EMRA subset. Furthermore, areas of high cytokine production (TNF + and IFN-γ + ) contain cells that either co-express KLRB1 and KLRG1 (pink arrows) or KLRG1 and GPR56 (purple arrows). These results from visual inspection of the t-SNE maps indicated that different combinations of these surface markers are characteristic for different functional states. As the acquisition or loss of cytokine expression potential is generally linked to the differentiation state of T cells, we wanted to analyze how the expression of the aforementioned set of surface markers correlates to the differentiation pathway of memory T cells according to the CD45RA/CCR7-based classification. For this, we applied the recently described wanderlust algorithm to construct a trajectory for CD4 + T-cell differentiation based on the classical surface marker CD45RA and CCR7, our surface marker set (KLRG1, KLRB1, KLRF1, and GPR56) and cytokine expression (TNF and IFN-γ) 26 . CD45RA + CCR7 + (T N ) cells were defined as initiator cells, thus determining the start point of the wanderlust plot.
We then examined the relative expression pattern of our selected surface markers but also levels of intracellular TNF and IFN-γ along the developmental trajectory by plotting them against the wanderlust axis (Fig. 3c ). According to this analysis, KLRB1 expression was the first marker to be acquired during CD4 + memory T-cell differentiation, a result which is confirmed by our bulk and single-cell-based gene expression analyses (Figs. 1 and 2). Subsequently, cells started to upregulate KLRG1 followed by a nearly parallel induction of GPR56. KLRF1 expression was only acquired at a late stage during memory T-cell differentiation. Interestingly, simultaneous to the upregulation of KLRB1, T cells obtained the potential to produce TNF and, with a slight delay, also IFN-γ. Whereas KLRB1 and KLRG1 showed a nearly constant increase in expression during differentiation, GPR56 and KLRF1 expression followed a two-phase pattern. Late-stage differentiated CD45RA re-expressing CD4 + T cells acquired very high KLRG1, GPR56, and KLRF1 expression but a reduction in KLRB1 expression concurrent with a decline in TNF and IFN-γ production.
Combinations of KLRs and GPR56 define memory T-cell states. The wanderlust analysis revealed a progressive acquisition of our surface markers during memory T-cell differentiation in the following order: KLRB1, KLRG1, GPR56, and KLRF1. Based on this, we analyzed whether T-cell subsets defined by this scheme would indeed recapitulate or even refine the known correlation between cytokine expression potential and stages of differentiation, which is currently describing T N cells as low, T EM cells as high, and T EMRA cells as exhausted cytokine producers (Fig. 4a, top row) .
To this end we defined the following subsets within total CD4 + T cells:
We analyzed each of their IFN-γ and TNF production (Fig. 4a , mid-row) to compare it with that of classically gated T cells, T N , T CM , T EM , and T EMRA cells. Indeed, the KLR/GPR56-based subset definition allowed categorization of cytokine production potential along CD4 + memory T-cell differentiation.
Interestingly, after primary acquisition of the initial marker KLRB1, the expression of this marker seemed to contribute little to the cytokine expression potential as KLRB1 + KLRG1 + GPR56 − KLRF1 − and KLRB1 − KLRG1 + GPR56 − KLRF1 − , as well as KLRB1 + KLRG1 + GPR56 + KLRF1 − and KLRB1 − KLRG1 + GPR56 + KLRF1 − subsets displayed only minor differences in cytokine production potential. In fact, the KLRB1 − subsets (Fig. 4a , bottom row) recapitulated the progressive acquisition of cytokine expression potential during memory T-cell differentiation and terminal exhaustion with acquisition of the KLRF1 marker (Fig. 4a) . Based on these results, we conclude that the combinatory expression profile of KLRB1, KLRG1, GPR56, and KLRF1 allows a refined classification of memory T-cell subsets along their differentiation line and correlates to their functional state, judging from their cytokine expression potentials (low, medium, high, or exhausted, Fig. 4b ). This refinement now facilitates the definition of the most potent cytokine-producing subsets; them being KLRB1 + KLRG1 + GPR56 − KLRF1 − , KLRB1 − KLRG1 + GPR56 + KLRF1 − , and especially KLRB1 + KLRG1 + GPR56 + KLRF1 − , which contained the highest proportion of TNF/IFN-γ co-producing cells (Fig. 4b) . Whereas no significant differences in proportion of TNF/IFN-γ co-producing cells between T EM and T EMRA cells could be detected, KLRB1 + KLRG1 + GPR56 + KLRF1 − cells contained significantly more than KLRB1 + KLRG1 + GPR56 + KLRF1 + cells. Furthermore, this progressive change in proportion of TNF/IFN-γ co-producing cells was not only observed upon PMA/Ionomycin stimulation, but also apparent when Staphylococcus enterotoxin B, tetanus toxoid (TT), or cytomegalovirus (CMV) peptides were used for restimulation ( Supplementary Fig. 3 ). Interestingly, whereas TTreactive T cells already accumulated in KLRB1 + KLRG1 − GPR56 − KLRF1 − cells, CMV-reactive TNF/IFN-γ co-producing cells were only detectable in KLRB1 + KLRG1 + GPR56 − KLRF1 − and KLRB1 + KLRG1 + GPR56 + KLRF1 − cells, most likely reflecting the frequency of antigen contact.
Having revealed that classically gated T EM cells contain less TNF and IFN-γ co-producing cells as compared with the most potent subsets of the KLR/GPR56 classification, we wondered whether T EM cells are in fact composed of different subsets according to our KLR/GPR56-based definition. Indeed, although the high cytokineproducing subsets made up the majority of T EM cells, populations with a low or exhausted functional state were also present (Fig. 4c) , which may explain the overall lower cytokine production potential in T EM cells compared with KLRB1 + KLRG1 + GPR56 + KLRF1 − cells (Fig. 4b) . Furthermore, classically gated T EMRA cells were composed of mainly exhausted populations (Fig. 4c) that therefore showed generally lower cytokine production potential (Fig. 4b) . Thus, the refined classification of memory T cells according to the KLR/GPR56 scheme reveals functional heterogeneity in the classical T EM and T EMRA subsets.
Inflammation shows increase in hepatic cytokine producers. In recent years, it became clear that significant phenotypical and functional differences exist between circulating and intra-tissue T cells 27, 28 . We therefore studied our newly defined memory Tcell surface marker panel on T cells derived from human liver tissue. First, we compared the proportions of CD4 + T cells displaying a classical T N , T CM , T EM , and T EMRA phenotype between blood of healthy controls, and blood and liver from patients with inflammatory biliary and hepatic diseases. As expected, T cells from liver samples contained the lowest proportions of T N and T CM cells but highest of T EM cells (Fig. 5a) . Interestingly, and somewhat unexpected, the proportion of T EMRA cells in some liver samples was lower than in the corresponding blood samples. Second, we performed single-cell gene expression profiling (genes listed in Supplementary Table 2) on sorted blood-and liver-derived T CM , T EM , and T EMRA cells of patients with inflammatory liver diseases (Fig. 5b) . Unsupervised hierarchical cluster analysis of selected candidate gene marker expression resulted in a separation of two main clusters, which differed in the proportion of KLRB1-, GPR56-, NKG7-, and KLRF1-expressing cells. The left cluster contained the majority of KLRB1-expressing cells and was dominated by T CM (blood and liver) cells with enrichment of liver T EM and T EMRA cells. In contrast, the majority of the blood T EM and T EMRA cells was contained within the right cluster, which showed a strong enrichment of GPR56-, KLRF1-, and partially KLRG1-expressing cells. This indicated that there was a qualitative difference between liver and blood-derived T EM and T EMRA cells. Indeed, the proportion of GPR56-, KLRG1-, and partially KLRF1-expressing T EM cells showed a tendency to be lower in liver samples, whereas the opposite was true for the proportion of KLRB1-expressing T EM cells ( Supplementary Fig. 4) .
These findings led us to investigate on protein level whether the proportions of T-cell subsets defined by the KLR/GPR56-based classification were different between blood and liver samples. Indeed, liver samples contained less of the low cytokineproducing T-cell subset KLRB1 − KLRG1 − GPR56 − KLRF1 − and had increased high cytokine-producing subsets KLRB1 − KLRG1 + GPR56 − KLRF1 − and KLRB1 + KLRG1 + GPR56 − KLRF1 − (Fig. 5c) . We also observed a reduction in the exhausted phenotypes KLRB1 − KLRG1 + GPR56 + KLRF1 + and KLRB1 + KLRG1 + GPR56 + KLRF1 + in the liver compared with blood samples. These changes in subset composition accumulate to a generally increased pro-inflammatory functionality of CD4 + T cells in the liver of patients compared with that in the blood. In line with this, liver T EM and T EMRA cells showed a clear reduction of functionally exhausted KLRF1 + subsets as compared with their blood counterparts (Fig. 6a) . Although the hepatic TNF and IFN-γ expression in the exhausted subsets was even lower than their blood-derived counterparts, all other subsets showed a generally increased cytokine production in the liver compared with the blood (Fig. 6b) .
Reduced TCRβ diversity in our proposed KLR/GPR56 pathway. In order to provide further evidence for the molecular relationship and linear differentiation of our proposed populations, we analyzed their T cell receptor (TCR) clonotypes by sequencing of the TCRβ chains. Thus, we performed fluorescence-activated cell sorting (FACS)-based enrichment of all five populations (1 = KLRB1 − KLRG1 − GPR56 − KLRF1 − , 2 = KLRB1 + KLRG1 − GPR56 − KLRF1 − , 3= KLRB1 + KLRG1 + GPR56 − KLRF1 − , 4= KLRB1 + KLRG1 + GPR56 + KLRF1 − , and 5= KLRB1 + KLRG1 + GPR56 + KLRF1 + ) from peripheral blood of healthy individuals followed by a TCRβ chain-sequencing analysis.
Interestingly, the frequency of TCR clones of cells belonging to the KLRB1 − KLRG1 − GPR56 − KLRF1 − subpopulation (population 1, Fig. 7 ) was rather low, whereas a progressive increase in clonal frequency was observed for T cells belonging to the other populations (Fig. 7a) . This indicates expansion of particular clonotypes, which is further supported by the decrease in TCRβ diversity along our proposed KLR/GPR differentiation path (Fig. 7b) .
Furthermore, the proposed subpopulations do not differentiate completely independent from each other, as TCR profiles overlapped especially between the late populations 4 and 5, but also 3 (Fig. 7c) , and TCR clones dominating in the late-stage differentiated populations 4 and 5 can be found in the early-stage populations 1 and 2 (Fig. 7d) . Taken together, these results further provide evidence for a linear differentiation along and molecular relationships between the proposed populations.
In vitro differentiation supports KLR/GPR56-based pathway.
Our results indicate that during human CD4 + memory T-cell differentiation changes in TNF and IFN-γ production are a result of progressive acquisition of KLRB1, KLRG1, GPR56, and KLRF1 expression.
To further validate our proposed differentiation pathway, we performed in vitro experiments by sorting the first four subpopulations (1 = KLRB1 − KLRG1 − GPR56 − KLRF1 − , 2= KLRB1 + KLRG1 − GPR56 − KLRF1 − , 3 = KLRB1 + KLRG1 + GPR56 − KLRF1 − , and 4 = KLRB1 + KLRG1 + GPR56 + KLRF1 − ) from the peripheral blood of healthy individuals followed by polyclonal stimulation with anti-CD3/CD28 antibodies. Unfortunately, the cell number of the fifth population (5 = KLRB1 + KLRG1 + GPR56 + KLRF1 + ) was too low to perform in vitro stimulation experiments.
The majority of the cells from the sorted populations kept their initial marker expression profile for 48 h, meaning that, e.g., only 2% of KLRB1 + KLRG1 − GPR56 − KLRF1 − cells (starting population 2) became KLRB1-or that 20% of KLRB1 + KLRG1 + GPR56 + KLRF1 − cells (starting population 4) lost GPR56 expression (Fig. 7e) . In contrast to the other populations, subset 3 (KLRB1 + KLRG1 + GPR56 − KLRF1 − ) did show a higher degree of plasticity with~40% of the cells becoming KLRB1 + KLRG1 − GPR56 − KLRF1 − . However, most importantly, the investigation revealed that the populations differentiate even further along the proposed path with, e.g., KLRB1 + KLRG1 + GPR56 − KLRF1 − cells (starting population 3) acquiring GPR56 but also KLRF1 expression.
In addition, we analyzed and compared the intracellular TNF and IFN-γ expression of the in vitro differentiated subsets (Fig. 7f) . Due to cell number limitations upon FACS-based enrichment, the experiments could be only done with the starting populations 1, 2, and 3. Upon in vitro differentiation, the subpopulations display the expected increase in proportions of TNF and IFN-γ double producers along the KLR/GPR56 pathway. The highest frequency was observed for KLRB1 + KLRG1 + GPR56 − KLRF1 − and KLRB1 + KLRG1 + GPR56 + KLRF1 − cells, whereas a decline was observed upon acquisition of KLRF1 expression.
Taken together, our findings introduce a surface marker classification scheme for CD4 + memory T cells, which recapitulates their differentiation pathway and more precisely links quantity of TNF and IFN-γ production to each subset compared with the classical CCR7/CD45RA-based index. This might be of 
Discussion
Ever since the first categorization of CD4 + or CD8 + T cells into populations defining their differentiation status based on CD45RA and CCR7 expression, discussions arose around the overall validity 9 . Indeed, recent findings on functional classification of CD8 + memory T cells have revealed that categorization based on CD62L or CCR7 expression, and thus lymph node homing properties, is not sufficient 29 . Therefore, it is not surprising that it was questioned whether the thereby defined subsets indeed represent homogeneous populations or whether individual cells differed greatly in their functional state [30] [31] [32] [33] [34] [35] , which for CD4 + T cells is mainly defined by their cytokine expression potential. We here addressed these questions for human CD4 + memory T cells and assessed cellular heterogeneity on single-cell level within classically gated CD4 + memory T lymphocytes from blood as well as from liver tissue of patients. As expected, we found pronounced heterogeneity within each subset on the overall transcriptional level, but also on the functional level assessed by single-cell cytokine secretion measurements. From these data, we developed a subset classification system based on the progressive acquisition of surface expression of the NK-cell-associated proteins KLRB1, KLRG1, GPR56, and KLRF1. We show that this classification thoroughly mirrors the memory differentiation line and is superior in indicating the cytokine production potential of the individual subsets compared with the classical CD45RA/ CCR7-based system.
Our findings on the progressive expression of multiple KLRs and GPR56 with final acquisition of KLRF1, resulting in a decline of cytokine production potential, is in line with published reports on murine CD8 + and CD4 + memory T cells. Analysis of phenotypic properties of murine CD8 + and CD4 + exhausted memory T cells revealed a correlation between decreased TNF/ IFN-γ co-production potential and progressive expression of multiple inhibitory receptors, such as PD-1, LAG-3, 2B4 (CD244), and CD160 or PD-1, CTLA4, CD200, and BTLA, respectively. 36, 37 . However, investigations on human memory T cells and in particular CD4 + memory T cells have been not performed so far.
Furthermore, the investigations on murine memory T cells were limited to the characterization of T cells with high effector function or non-functional exhausted T cells, and did not allow following the complete memory T-cell development. Incorporating single-cell gene expression profiling, Wanderlust analysis and TCRβ chain sequencing enabled us to propose an alternative path of human CD4 + memory T-cell development defining populations with low, medium, high, and finally exhausted functional states. In our screen, expression pattern of KLRB1, 2.3 ± 0.6% 0.5 ± 0.3% 1.5 ± 0.5% 1.6 ± 0.6% 14.2 ± 4.3% 12.1 ± 5.4% 13.7 ± 2.8% 39.0 ± 7.0% 1.5 ± 0.5% 5.1 ± 1.2% 19.6 ± 5.5% 28.6 ± 6.2% 11.5 ± 2.4% 16.0 ± 3.5% 1.8 ± 0. KLRG1, GPR56, and KLRF1 appeared to be most informative. Although PD-1 expression is described to be associated with Tcell exhaustion 38 and thus terminal differentiation of T cells, our initial RNA microarray analysis did not reveal a significant enrichment of PD-1 transcription within CD4 + T EM and T EMRA cells, as we also observed transcription in T CM cells. Furthermore, our PD-1 protein expression analysis revealed a high expression in T CM and especially T EM cells but a reduction in T EMRA cells. Our four identified surface markers, KLRB1, KLRG1, GPR56, and KLRF1, were all first described in relation to their high expression in NK cells 17, [39] [40] [41] [42] , indicating similarities between NK cell differentiation and memory/effector T-cell development. The C-type lectin KLRB1, also known as CD161, has been shown to be expressed by CD4 + and CD8 + T cells. For CD4 + T cells, KLRB1 expression was mainly ascribed to IL-17-producing Th17 cells 25 . However, other recent publications identified also broader KLRB1 expression across different T-cell lineages expressing, e.g., IL-17 or TNF/IFN-γ, which is in agreement with our findings [43] [44] [45] . For NK cells, KLRB1 ligation was long thought to trigger only inhibitory signals 43 . However, a recent report revealed pro-inflammatory functions of KLRB1 + NK cells 46 . Also, for T cells inhibitory and costimulatory roles have been proposed 43 . Indeed, our results also revealed a significant increase in cytokine-producing CD4 + memory T cells with acquisition of KLRB1 expression. Interestingly, we did observe differences between KLRB1 transcription and protein expression. Whereas KLRB1 transcription was mainly limited to T CM and T EM cells, protein expression was observed for T CM , T EM , as well as T EMRA cells. In addition, T EMRA cells (Fig. 2a) positive for KLRB1 and the most exhausted KLRB1 + KLRG1 + GPR56 + KLRF1 + cells showed reduced KLRB1 expression per cell.
The KLRG1 is a marker for T-cell senescence, as expressing cells have limited proliferative capacity 18, 20 . However, KLRG1-expressing T cells are not exhausted, as they display cytokine production and cytotoxic potential 47 . KLRG1 expression is supposed to be limited to tissue-homing and thus T EM and T EMRA cells 8, 28, [48] [49] [50] . Our own data showed that also a significant proportion (≈22 %) of CCR7-expressing T CM cells were KLRG1 + . These findings are in agreement with other published reports showing that also T CM cells can express KLRG1, which was associated with increased production of effector cytokines 35 . Indeed, our results also revealed a dramatic increase of cytokine production potential as soon as the T cells acquired KLRG1 expression.
Already in the first report describing the NK cell triggering activity of KLRF1, also known as NKp80, its expression on a subset of T cells was observed 42 . In addition, it was shown that NKp80 ligation can augment CD3-stimulated degranulation and IFN-γ secretion by effector memory CD8 + T cells 51 . This is contradictory to the here described results, as KLRF1 acquisition was associated with a decline in cytokine production potential. However, our investigations were performed on CD4 + T cells and, at least in mice, different properties for CD4 + in comparison with CD8 + T cells were recently described 37 . It remains to be investigated whether KLRF1 plays an inhibitory role for human CD4 + memory T-cell activation. Nevertheless, KLRF1 expression was able to identify CD4 + memory T cells with reduced cytokine production potential regardless of cohort (healthy control vs. patient) or tissue-type origin.
GPR56 was shown to be expressed by cytotoxic NK and T lymphocytes including CD8 + , CD4 + , and γδ + T cells 41 . For NK cells, an inhibitory role for GPR56 in controlling steady-state activation by associating with the tetraspanin CD81 was revealed 52 . Similar to KLRF1, the role of GPR56 for stimulationdependent production of cytokines by human CD4 + T cells is unknown and needs to be investigated in further studies. In support of our findings, a recent report by Tian et al. 53 also showed that CD4 + T EMRA cells are heterogeneous and can be subdivided into at least two subpopulations based on their GPR56 expression. In their publication, the authors focussed on the cytotoxic potential and did not study the cytokine production potential in greater detail. Furthermore, our results now show that GPR56 in conjunction with expression of KLRs is not limited to reveal functional heterogeneity of T EMRA cells in blood but also of T EMRA and T EM cells residing in the liver.
Our results on successful induction of, e.g., KLRG1 and GPR56 or even KLRF1 expression upon in vitro stimulation of sorted subsets further supports our hypothesis on progressive expression of killer-like receptors and GPR56, describing an initial increase and final decline in cytokine production potential. This is also in line with our previous findings on linear differentiation from T CM , via T EM , and towards T EMRA cells 54 . There we detected a progressive change in the epigenome of the cells, which could explain the progressive expression pattern described here.
Finally, our results with increased T EM but decreased or equal T EMRA frequencies in the liver in comparison with that in the blood is in agreement with recent descriptions on spatial mapping of human T-cell compartmentalization 11 . Although the authors did not investigate liver tissue, they did report increased T EM frequencies within intestinal and lung tissues compared with that in the blood, whereas T EMRA frequencies did not vary. However, the here reported combinational expression pattern of KLRs and GPR56 challenges the usefulness and gain of analyzing overall T EM and T EMRA frequencies, as analysis of KLR/GPR56 composition seems to be superior in discriminating between high and exhausted cytokine-producing cell subsets, with the exhausted subsets being decreased in intrahepatic CD4 + T EM and T EMRA cells in comparison with their blood equivalents.
In summary, our data reveal that identifying human CD4 + memory T-cell populations based on the expression pattern of KLRB1, KLRG1, GPR56, and KLRF1 enables a better definition of functional states especially in peripheral tissues as compared with the classical CD45RA/CCR7-based categorization. These findings improve understanding of CD4 + memory T-cell development and function, and thus might have implications for clinical diagnostics and development of more target-specific immune therapies. It will be interesting to see whether the here described combinational expression profile and functional subsets might aid in improving prediction of disease progression in inflammatory diseases or in therapeutic efficacy upon vaccination or checkpoint inhibition.
Methods
Samples. Heparinized blood and liver samples were collected from patients with written consent undergoing partial liver resection or hepatectomy followed by liver transplantation. Patients included suffered from following diseases: liver cirrhosis, hepatocellular carcinoma, liver metastases, and cancerous diseases of the biliary tract, including Caroli disease, gall bladder carcinoma, cholangiocellular carcinoma, and Klatskin tumor. Median age of the patients was 68 years, ranging from 52 to 81 years. Liver samples were taken from non-cancerous and non-necrotic parts of the resected liver tissue and were preserved in Hank's balanced salt solution (HBSS, Gibco, Thermo Fisher Scientific, UK). Heparinized blood from age-matched healthy individuals was collected. All samples were processed within an hour after retrieval.
Sample collection was performed following the Declaration of Helsinki, the European Guidelines on Good Clinical Practice, with permission from the relevant national and regional authority requirements and ethics committees (EA2/044/08, EA1/116/13, EA2/020/14, EA1/290/16, EA1/291/16 & EA1/292/16, Ethics Committee of the Charité Berlin). All patients gave written consent.
Isolation of PBMC cells. PBMC cells were isolated at room temperature by density gradient centrifugation (Biocoll, Biochrom, Germany) of heparinized blood diluted 1:2 in phosphate-buffered saline (PBS, Gibco, Thermo Fisher Scientific, UK). Cell number was determined using a hemocytometer. Isolated PBMCs were directly used for sorting, stimulation, or cryopreservation.
Isolation of intrahepatic lymphocytes. Liver tissue was dissected into 1 mm 3 fragments and digested with agitation (75-80 r.p.m.) at 37°C for 30 min in a digestive solution containing 2% fetal calf serum (FCS, Biochrom), 0.6% bovine serum albumin (BSA), 0.05% collagenase type IV (Sigma-Aldrich, Germany), and 0.002% DNAse I (Sigma-Aldrich, Germany) per 1 g tissue and 10 ml. Undissociated tissue was pressed through a steel sieve and dissolved in same solution. Dissociated tissue in solution was centrifuged at 500 × g. Tissue components were diluted in HBSS. Tissue suspension was centrifuged at 30 × g to separate and discard the hepatocyte-rich matrix. Still undissociated tissue was removed by filtration through 100 µm nylon mesh, leaving a cell suspension. Hepatocytes were removed using a 33% Biocoll density gradient centrifugation. Cells were washed with HBSS and red blood cell lysis was performed using distilled water. Isolated intrahepatic lymphocytes (IHLs) were cryopreserved in liquid nitrogen.
Surface staining and T-cell subset sorting. CD4+ T cells were enriched by magnetic activated cell sorting (MACS) using 20 µl of anti-CD4 MicroBeads (anti-CD4 microbeads, human, Miltenyi Biotec, Germany) and 80 µl MACS buffer (PBS with 0.5% BSA and 2 mM ethylenediaminetetraacetic acid) per 10 7 cells. CD4+ T cells were stained for surface expression in MACS buffer at a concentration of 2 × 10 8 cells/ml. Cells were washed and stained with 4′,6-diamidino-2-phenylindole (1:250) and then sorted using the flow cytometer BD FACSAria II (BD Biosciences, Germany) into the following CD4+ T-cell subpopulations: Treg (CD25highCD127low) and non-Treg: TN (CD45RA+ CCR7+), TCM (CD45RA-CCR7+), TEM (CD45RA− CCR7−), and TEMRA (CD45RA+ CCR7−).
Antibodies used for surface staining were anti-CCR7 (GO43H7, RNA microarray analysis. Total RNA from sorted T-cell populations was isolated using TRIzol (Thermo Fisher Scientific, Bremen, Germany). RNA quality and integrity were determined using the Agilent RNA 6000 Nano Kit on the Agilent 2100 Bioanalyzer (Agilent Technologies). RNA was quantified by measuring light absorbance at 260 nm on a spectrophotometer (NanoDrop Technologies).
Sample labeling was performed as detailed in the One-Color Microarray-Based Gene Expression Analysis protocol (version 6.6, part number G4140-90040). Briefly, 10 ng of each total RNA samples was used for the amplification and labeling step using the Agilent Low Input Quick Amp Labelling Kit (Agilent Technologies). Yields of cRNA and the dye-incorporation rate were measured with the ND-1000 Spectrophotometer (NanoDrop Technologies).
The hybridization procedure was performed according to the One-Color Microarray-Based Gene Expression Analysis protocol (version 6.6, part number G4140-90040) using the Agilent Gene Expression Hybridization Kit (Agilent Technologies). Briefly, 1.65 µg Cy3-labeled fragmented cRNA in hybridization buffer was hybridized overnight (17 h, 65°C) to Agilent Whole Human Genome Custom Oligo Microarrays 4 × 44 K (AMADID 014850) using Agilent's recommended hybridization chamber and oven. Following hybridization, the microarrays were washed once with the Agilent Gene Expression Wash Buffer 1 for 1 min at room temperature followed by a second wash step with preheated Agilent Gene Expression Wash Buffer 2 (37°C) for 1 min. The last washing step was performed with acetonitrile.
Single-cell gene expression analysis. The C1 Single-Cell Auto Prep System (Fluidigm, South San Francisco, CA, USA) was used for single-cell isolation and pre-amplification to prepare separate single-cell cDNA in a 5-10 µm C1 Single-Cell PreAmp Integrated Fluidic Circuit (IFC) within a C1-Chip. For single-cell isolation, a cell suspension of at least 660,000 cells/ml was used, which enabled at least 2000 cells to enter the C1-chip. Visualization of cell loading (empty, single, doublets, or debris) was done using a light microscope. Single-cell capture rates were documented. Cell lysis, reverse transcription, and pre-amplification were performed on the C1-chip. cDNA of each cell was collected for qRT-PCR preparation. cDNAs and 48 TaqMan gene expression assays (Thermo Fisher Scientific), including B2M (beta-2-microglobulin) and an RNA spike-in (spike 1) as control values, were applied to the BioMark Gene Expression 48.48 IFC for gene expression analysis. Information on all TaqMan gene expression assays used are listed in Supplementary Table 2 . Detailed workflow can be found in the Fluidigm Real-Time PCR User Guide (PN 68000088).
Cell stimulation and intracellular cytokine staining. Freshly isolated or thawed PBMCs or IHLs (5 × 10 6 ) were stimulated with phorbol myristate acetate (50 ng/ml, Sigma-Aldrich, Germany) and ionomycin (1 µg/ml, Biotrend, Germany) for 6 h, Tetanus Toxid (40 LF/ml, AJ Vaccines, Denmark), or Staphylococcal enterotoxin B (100 µg/ml, Sigma-Aldrich, Germany) and anti-CD28 (1 µg/ml, BD Pharmingen, Germany) for 24 h (37°C, 5 % CO 2 ).
CD4+ T cells enriched from freshly isolated PBMCs from healthy donors (CD4 MicroBeads, Miltenyi Biotec) were sorted for indicated marker expression using a BD FACSAria II. Sorted cells were stimulated with plate-bound anti-CD3 (1 µg/ml, BD Pharmingen, Germany) and soluble anti-CD28 (2 µg/ml, BD Pharmingen, Germany) in 96-well plates with 1 × 10 5 cells/well and treated with TGF beta RI kinase inhibitor II (50 ng/ml, Calbiochem, Merck, Germany) for 72 h. In all stimulation cultures, Brefeldin A (10 µg/ml, Sigma-Aldrich, Germany) was added during the last 4 h.
Cells were washed once with PBS and stained with Zombie UV Fixable Viability Kit (BioLegend, USA) for 15 min. Cell surface staining was performed as described above. Afterwards, cells were fixed and permeabilized (BD Cytofix/Cytoperm Fixation and Permeabilization Solution, BD Biosciences, Germany) for 20 min.
After washing twice with Perm/Wash buffer (BioLegend, USA), cells were stained intracellularly for 30 min. Antibodies used for intracellular staining were anti-TNF (Mab11, 1:200), anti-IFN-γ (4 S.B3, 1:100), anti-IL-4 (MP4-25D2, 1:50), anti-IL-17A (BL168, 1:20), anti-CD3 (OKT3, 1:100) (all BioLegend), and GPR56 (REA467, Miltenyi Biotec, 1:10). Samples were washed and acquired on a BD LSRFortessa (BD Biosciences, Germany). Data analysis was performed using FlowJo software version 10.1 (FlowJo, LLC, Ashland, OR, USA).
Bioinformatical analysis of flow cytometry data. To generate and visualize wanderlust trajectories of developmental changes in marker expression of CD4 + T cells, we used the Matlab Cyt toolbox 26 . The algorithm was run on CD8 − nonTreg (exclusion of CD4 + CD25 high CD127 low cells) pre-gated PMA/Ionomycin stimulated samples. In order to apply Wanderlust to samples where all gradual differentiation states are present, FCS files were selected to have a high proportion of T EMRA cells (5 healthy individuals) and density-dependent down-sampled to a total 50,000 cells using the R SPADE package 55 .
Utilizing the Cytobank viSNE tool, t-SNE maps were generated for CD8 − pregated T cells (w/o CD25 high CD127 low cells) of PMA/Ionomycin-stimulated samples, allowing for visualization of the phenotypic and functional heterogeneity at single-cell level 56, 57 . CCR7, CD45RA, KLRB1, KLRF1, KLRG1, GPR56, TNF, and IFN-γ were selected for both Wanderlust and t-SNE dimension reduction.
Bioinformatical analysis of RNA microarray data. Fluorescence signals of the hybridized Agilent Microarrays were detected using Agilent's Microarray Scanner System G2505C (Agilent Technologies). The Agilent Feature Extraction Software (FES) 10.7.3.1 was used to read out and process the microarray image files.
After quantile normalization, pair-wise t-tests were conducted between T EMRA and T EM , T CM , and T N , and between T EM and T CM , and T N , respectively. The intersection analysis of T EMRA vs. T N , T EMRA vs. T CM , and T EMRA vs. T EM ( = T EMRA vs. T N /T CM /T EM ) included genes with an at least twofold upregulation (p < 0.05) in the T EMRA group in each of the pair-wise comparisons. The selection T EMRA /T EM vs. T N /T CM included genes with an at least twofold upregulation (p < 0.05) in each of the comparisons T EMRA vs. T N , T EMRA vs. T CM , T EM vs. T N , and T EM vs. T CM . Genes expressed on the cell surface were extracted from the human cell surfaceome described in da Cunha et al. 58 .
Bioinformatical analysis of single-cell qRT-PCR results. qPCR data were extracted by using the Fluidigm Real-Time PCR Analysis Software. R, version 3.1, was used for the statistical and hierarchical cluster analysis (R_Core_Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria URL http://www.r-projectorg/ 2014). The data contained the gene expression level (Log 2 Ex), calculated by subtracting gene Ct values from limit of detection (LoD) Ct. Default LoD is preset to Ct 24. By analyzing the distribution of the gene expression level of each nest for each gene, we adjusted the LoD of certain genes to only include noise-free data. Samples with undetectable B2m and Spike 1 expression, as well as genes expressed by <10 cells were excluded. Heatmaps for single-cell Log 2 Ex data were generated using Euclidean distance measure and Wards method for agglomerative hierarchical clustering. Binary heatmap coloring was chosen to indicate positive and negative marker expression according to the individual LoDs.
TCRβ chain-sequencing and data analysis. Next-generation sequencing was performed for TCR repertoire analysis. Recombined TCR-b locus was amplified as previously described 59 . Sequencing library preparation with consequent sequencing was performed using Illumina MiSeq Technology at the Genomics Unit at Centre for Genomic Regulation (Barcelona, Spain). Reads with an average quality score below 30 were excluded from the analysis. The remaining high-quality reads were processed using IMSEQ 60 . Each clonotype was assigned an ID including Vβ-and Jβ-gene identity, as well as CDR3 amino acid sequence.
The similarity of the top 100 expanded clones of two populations was determined by the Morisita-Horn similarity index 61 , which considers the abundance of each sequence in each population. The index is given by:
where P is the total number of sequences in one population, Q is the total number of sequences in the second population, and n PQ is the the total number of unique sequences in the two populations; p i is the proportion of the ith sequence in population P; q i is the proportion of the ith sequence in population Q. The index ranges from 0 to 1, where 0 is total dissimilarity and 1 is identical populations. Clonal diversities of the TCRβ repertoires were evaluated for the top 100 expanded clones using Reńyi diversity profiles 62 :
H α being the entropy; n the total number of unique sequences; p i the proportion of the ith sequence, and α a scaling parameter. By varying the α parameter, different diversity indices are calculated, such as the logarithm to the reciprocal Simpson diversity index at α ¼ 2. At α ¼ 1, the Reńyi diversity is approximated by the Shannon diversity index. At α ¼ 0 and α ¼ 1, the profiles provide the logarithm of richness and the logarithm of the reciprocal to the proportion of the most abundant sequence (Berger-Parker Index), respectively. This means that the sample with the highest value at α ¼ 0 has the highest richness, but that the lower value at α ¼ 1 indicates higher proportion of the most abundant sequence. A sample with a profile that is overall higher than the profiles of other samples is more diverse. Conversely, if the profiles cross at one point no ranking in diversity can be performed.
